08.21.14
Northbrook, Ill.-based Nanosphere Inc. has named Kristopher Wood to its board of directors. Wood brings a background of finance, strategy and venture capital to the targeted molecular diagnostics company.
“We are pleased to welcome Kris to the board,” said Michael McGarrity, president, CEO and board member. “We believe his background is well suited to help us create value for our shareholders and accelerate our top line growth.”
Wood is currently the sole member of Highline Partners, LLC, a consultancy through which he serves in the capacity of chief investment officer at Lurie Holdings Inc. and as special advisor on strategic matters to New Page Corporation and its board of directors. Prior to forming Highline Partners, from 2009 to 2011, Wood served as head of strategy and corporate development at WorldColor Press Inc. He served from 2007 to 2009 as an associate at MidOcean Partners, a private equity investment firm based in New York and London. Wood also served as chief acquisitions officer for Glenayre Inc. and as managing director for mergers and acquisitions and venture capital at Vertis Holdings Inc. and its predecessor, Big Flower Holdings Inc. He currently serves on the boards of directors for several privately-held companies. Wood received a BS in economics from the Wharton School of the University of Pennsylvania.
“I welcome the opportunity to join the Nanosphere board during this critical time,” said Wood. “I look forward to working with the Nanosphere team to help drive shareholder value.”
Nanosphere’s targeted molecular diagnostics are aimed at producing earlier disease detection, optimal patient treatment and improved healthcare economics. The company’s technology platform, the Verigene System, is deigned to rapidly detect complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test.
“We are pleased to welcome Kris to the board,” said Michael McGarrity, president, CEO and board member. “We believe his background is well suited to help us create value for our shareholders and accelerate our top line growth.”
Wood is currently the sole member of Highline Partners, LLC, a consultancy through which he serves in the capacity of chief investment officer at Lurie Holdings Inc. and as special advisor on strategic matters to New Page Corporation and its board of directors. Prior to forming Highline Partners, from 2009 to 2011, Wood served as head of strategy and corporate development at WorldColor Press Inc. He served from 2007 to 2009 as an associate at MidOcean Partners, a private equity investment firm based in New York and London. Wood also served as chief acquisitions officer for Glenayre Inc. and as managing director for mergers and acquisitions and venture capital at Vertis Holdings Inc. and its predecessor, Big Flower Holdings Inc. He currently serves on the boards of directors for several privately-held companies. Wood received a BS in economics from the Wharton School of the University of Pennsylvania.
“I welcome the opportunity to join the Nanosphere board during this critical time,” said Wood. “I look forward to working with the Nanosphere team to help drive shareholder value.”
Nanosphere’s targeted molecular diagnostics are aimed at producing earlier disease detection, optimal patient treatment and improved healthcare economics. The company’s technology platform, the Verigene System, is deigned to rapidly detect complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test.